L. Mary Smith

Insider Reports History

Entity
Individual
Location
C/O Springworks Therapeutics, Inc., 100 Washington Blvd., Stamford, CT
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by L. Mary Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Chief Development Officer Common Stock 233K $9.69M $41.53 Jan 8, 2024 Direct
SpringWorks Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 60K Jan 4, 2024 Direct

Insider Reports Filed by L. Mary Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SWTX SpringWorks Therapeutics, Inc. Jan 4, 2024 4 -$230K 4 Jan 8, 2024 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2023 1 -$28.2K 4 Jan 10, 2023 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jan 5, 2023 4 -$67.5K 4 Jan 9, 2023 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jul 18, 2022 1 -$44.2K 4 Jul 20, 2022 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2022 1 -$66.2K 4/A Jan 14, 2022 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jan 6, 2022 2 $0 4 Jan 10, 2022 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Oct 13, 2021 3 -$537K 4 Oct 13, 2021 Chief Development Officer
SWTX SpringWorks Therapeutics, Inc. Jul 13, 2021 3 -$786K 4 Jul 14, 2021 Chief Development Officer